Lapatinib Completed Phase 1 Trials for Metastatic Colorectal Cancers / Advanced Colorectal Cancer / Responsive to Fluoropyrimidines / Neoplasms, Colorectal Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00536809Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer